Abstract
Right unilateral ultrabrief pulse (RUL-UBP) ECT has emerged as a promising technique for minimizing cognitive side effects of ECT while retaining clinical efficacy, but it is unknown how often patients will require alternative treatment parameters and at what point in the treatment course this occurs. To better define this problem, this study analyzes continuation in RUL-UBP ECT in a retrospective cohort of patients beginning acute course treatment. A single-center retrospective chart review was conducted of adult patients receiving a first lifetime course of ECT from 2010 to 2017 starting with RUL-UBP treatment parameters. 1793 patients met study criteria. Patients received a mean of 10.0 ± 3.2 ECT treatments, of which a mean of 8.4 ± 3.4 were RUL-UBP treatments; proportion using RUL-UBP through 12 treatments was 57.8%. In total, 65.6% of patients were treated with RUL-UPB ECT exclusively. Mean dose increased from 7.6 × seizure threshold at the second RUL-UBP treatment to 14.3 × seizure threshold at the twelfth RUL-UBP treatment. Rates of continuation in RUL-UBP ECT did not differ based on age or on primary diagnosis of major depression vs. bipolar disorder. Among patients beginning acute-course treatment using RUL-UPB ECT, two thirds were treated with these parameters exclusively. Among patients who received twelve RUL-UBP treatments, mean final dose was 14.3 × seizure threshold. Further studies regarding optimal dosing of RUL-UBP ECT are indicated.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
References
Mutz J, Vipulananthan V, Carter B et al (2019) Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ. https://doi.org/10.1136/bmj.l1079
Sackeim HA (2017) Modern electroconvulsive therapy: vastly improved yet greatly underused. JAMA Psychiatry 74:779–780. https://doi.org/10.1001/jamapsychiatry.2017.1670
Peterchev AV, Rosa MA, Deng Z-D et al (2010) Electroconvulsive therapy stimulus parameters: rethinking dosage. J ECT 26:159–174. https://doi.org/10.1097/YCT.0b013e3181e48165
Spaans H-P, Kho KH, Verwijk E et al (2013) Efficacy of ultrabrief pulse electroconvulsive therapy for depression: a systematic review. J Affect Disord 150:720–726. https://doi.org/10.1016/j.jad.2013.05.072
Galletly C, Clarke P, Paterson T et al (2014) practical considerations in the use of ultrabrief ECT in clinical practice. J ECT 30:10–14. https://doi.org/10.1097/YCT.0000000000000081
Tor P-C, Bautovich A, Wang M-J et al (2015) A systematic review and meta-analysis of brief versus ultrabrief right unilateral electroconvulsive therapy for depression. J Clin Psychiatry 76:e1092-1098. https://doi.org/10.4088/JCP.14r09145
Lapidus KAB, Kellner CH (2011) When to switch from unilateral to bilateral electroconvulsive therapy. J ECT 27:244–246. https://doi.org/10.1097/YCT.0b013e31820059e1
Luccarelli J, McCoy THJ, Seiner SJ, Henry ME (2020) Total charge required to induce a seizure in a retrospective cohort of patients undergoing dose titration of right unilateral ultrabrief pulse electroconvulsive therapy. J ECT Publish Ahead of Print: https://doi.org/10.1097/YCT.0000000000000714
Kellner CH, Knapp RG, Petrides G et al (2006) Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the consortium for research in electroconvulsive therapy (CORE). Arch Gen Psychiatry 63:1337–1344. https://doi.org/10.1001/archpsyc.63.12.1337
Kellner CH, Husain MM, Knapp RG et al (2016) Right unilateral ultrabrief pulse ECT in geriatric depression: phase 1 of the PRIDE study. Am J Psychiatry 173:1101–1109. https://doi.org/10.1176/appi.ajp.2016.15081101
Brakemeier E-L, Merkl A, Wilbertz G et al (2014) Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial. Biol Psychiatry 76:194–202. https://doi.org/10.1016/j.biopsych.2013.11.030
Luccarelli J, Henry ME, McCoy THJ (2020) Demographics of patients receiving electroconvulsive therapy based on state-mandated reporting data. J ECT Publish Ahead of Print: https://doi.org/10.1097/YCT.0000000000000692
Kerner N, Prudic J (2014) Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry 4:33–54. https://doi.org/10.2217/npy.14.3
Bloch Y, Ratzoni G, Sobol D et al (2005) Gender differences in electroconvulsive therapy: a retrospective chart review. J Affect Disord 84:99–102. https://doi.org/10.1016/j.jad.2004.10.002
Dierckx B, Heijnen WT, van den Broek WW, Birkenhäger TK (2012) Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. Bipolar Disord 14:146–150. https://doi.org/10.1111/j.1399-5618.2012.00997.x
Bahji A, Hawken ER, Sepehry AA et al (2019) ECT beyond unipolar major depression: systematic review and meta-analysis of electroconvulsive therapy in bipolar depression. Acta Psychiatr Scand 139:214–226. https://doi.org/10.1111/acps.12994
Sackeim HA, Prudic J, Nobler MS et al (2008) Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimulat 1:71–83. https://doi.org/10.1016/j.brs.2008.03.001
Coffey CE, Lucke J, Weiner RD et al (1995) Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT. Biol Psychiatry 37:777–788. https://doi.org/10.1016/0006-3223(95)00053-J
Fink M, Petrides G, Kellner C et al (2008) Change in seizure threshold during electroconvulsive therapy. J ECT 24:114–116. https://doi.org/10.1097/YCT.0b013e31815f65b9
Semkovska M, Landau S, Dunne R et al (2016) Bitemporal versus high-dose unilateral twice-weekly electroconvulsive therapy for depression (EFFECT-Dep): a pragmatic, randomized, non-inferiority trial. Am J Psychiatry 173:408–417. https://doi.org/10.1176/appi.ajp.2015.15030372
McCall WV, Reboussin DM, Weiner RD, Sackeim HA (2000) Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 57:438–444. https://doi.org/10.1001/archpsyc.57.5.438
van Waarde JA, Verwey B, van der Mast RC (2009) Meta-analysis of initial seizure thresholds in electroconvulsive therapy. Eur Arch Psychiatry Clin Neurosci 259:467. https://doi.org/10.1007/s00406-009-0011-7
Luccarelli J, McCoy TH, Seiner SJ, Henry ME (2020) Charge required to induce a seizure during initial dose titration using right unilateral brief pulse electroconvulsive therapy. Brain Stimul Basic Transl Clin Res Neuromodulation. https://doi.org/10.1016/j.brs.2020.08.009
Abbott CC, Quinn D, Miller J et al (2020) Electroconvulsive therapy pulse amplitude and clinical outcomes. Am J Geriatr Psychiatry. https://doi.org/10.1016/j.jagp.2020.06.008
Devanand DP, Lisanby SH, Nobler MS, Sackeim HA (1998) The relative efficiency of altering pulse frequency or train duration when determining seizure threshold. J ECT 14:227–235
Roepke S, Luborzewski A, Schindler F et al (2011) Stimulus pulse-frequency-dependent efficacy and cognitive adverse effects of ultrabrief-pulse electroconvulsive therapy in patients with major depression. J ECT 27:109–113. https://doi.org/10.1097/YCT.0b013e3181e63302
Funding
This work was supported by the National Institute of Mental Health (R25MH094612, JL; R56MH115187 and R01MH120991, THM; 5R01MH112737-03, MEH), the National Institute on Aging (5R01AG061100-02; BPF), and the Brain and Behavior Research Foundation (NARSAD 26489; THM). The sponsors had no role in study design, writing of the report, or data collection, analysis, or interpretation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
THM receives research funding from the Stanley Center at the Broad Institute, the Brain and Behavior Research Foundation, National Institute of Mental Health, National Human Genome Research Institute Home, and Telefonica Alfa. Dr. Forester receives research support from the National Institute on Aging, Biogen, Lilly, the Rogers Family Foundation, and the Spier Family Foundation. He reports consulting for Biogen. The remaining authors have no disclosures to report.
Ethical approval
This study was approved by the Partners Healthcare Institutional Review Board.
Electronic supplementary material
Below is the link to the electronic supplementary material.
406_2020_1202_MOESM1_ESM.docx
Figure S1: Histogram of RUL-UBP charges applied during acute course treatment. Of the 15,118 RUL-UBP treatments, 12,018 (79.5%) used one of four doses: 19.2 mC (generally for treatment #1), 115.2 mC, 230.4 mC, and 345.6 mC (DOCX 36 kb)
Rights and permissions
About this article
Cite this article
Luccarelli, J., McCoy, T.H., Shannon, A.P. et al. Rate of continuing acute course treatment using right unilateral ultrabrief pulse electroconvulsive therapy at a large academic medical center. Eur Arch Psychiatry Clin Neurosci 271, 191–197 (2021). https://doi.org/10.1007/s00406-020-01202-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-020-01202-2